<?xml version="1.1" encoding="utf-8"?>
<article xsi:noNamespaceSchemaLocation="http://jats.nlm.nih.gov/publishing/1.1/xsd/JATS-journalpublishing1-mathml3.xsd" dtd-version="1.1" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"><front><journal-meta><journal-id journal-id-type="publisher-id">MRP</journal-id><journal-title-group><journal-title>Medical Research and Practice</journal-title></journal-title-group><issn>2993-9690</issn><eissn>2993-9704</eissn><publisher><publisher-name>Art and Design</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="doi">10.61369/MRP.2025070006</article-id><article-categories><subj-group subj-group-type="heading"><subject>Article</subject></subj-group></article-categories><title>胃肠道间质瘤的免疫微环境特征及其治疗进展研究</title><url>https://artdesignp.com/journal/MRP/3/7/10.61369/MRP.2025070006</url><author>曹景怡,张晨,荆哲,庄坤</author><pub-date pub-type="publication-year"><year>2025</year></pub-date><volume>3</volume><issue>7</issue><history><date date-type="pub"><published-time>2025-07-20</published-time></date></history><abstract>胃肠间质瘤（gastrointestinal &amp;nbsp; &amp;nbsp;stromal &amp;nbsp; &amp;nbsp;tumor, &amp;nbsp; &amp;nbsp;GIST）是一类源自间叶组织的消化道常见肿瘤，近年来，随着对其发病机制的深入探索，其在肿瘤免疫微环境（tumor &amp;nbsp; &amp;nbsp;immune &amp;nbsp; &amp;nbsp;microenvironment, &amp;nbsp; &amp;nbsp;TIME）中的特征逐渐受到广泛关注。研究发现，GIST的发生与发展密切依赖其特有的免疫微环境构成及调控网络。随着免疫治疗的快速发展，系统解析GIST中免疫微环境的组成、功能及其动态调控机制，已成为提升治疗响应率、推动新型疗法开发的关键方向。本文系统综述了GIST免疫微环境的主要特征及其在肿瘤进展中的作用，分析当前生物治疗的潜力与局限，并结合最新研究进展，提出未来可能的研究与临床转化路径。</abstract><keywords>免疫微环境,胃肠道间质瘤,免疫治疗,靶向治疗</keywords></article-meta></front><body/><back><ref-list><ref id="B1" content-type="article"><label>1</label><element-citation publication-type="journal"><p>[1] Pantaleo M A, Tarantino G, Agostinelli C, et al. [J]. 2019. Taylor &amp;amp; Francis.&amp;nbsp;[2] Roulleaux Dugage M, Jones R L, Trent J, et al. Beyond the driver [J]. Unknown Journal, 2021.&amp;nbsp;[3] Unknown authors. Int J Clin Exp Pathol, 2014, 7(7): 3563-3579.&amp;nbsp;[4] Arshad J, Costa P A, Barreto-Coelho P, et al. Immunotherapy strategies for gastrointestinal stromal tumor [J]. Cancers, 2021, 13(14): 3525.&amp;nbsp;[5] Dimino A, Brando C, Algeri L, et al. Exploring the dynamic crosstalk between the immune system and genetics in gastrointestinal stromal tumors [J]. Cancers, 2023, 15(1): 216.&amp;nbsp;[6] Dimino A, Brando C, Algeri L, et al. [J]. Cancers, 2022.&amp;nbsp;[7] Rusakiewicz S, Semeraro M, Sarabi M, et al. [J]. Cancer, 2013.&amp;nbsp;[8] Husain Z, et al. [J]. Cell Metabolism, 2017.&amp;nbsp;[9] Serrano C, George S. [J]. Clinical Cancer Research, 2020.&amp;nbsp;[10] Chantharasamee J, Adashek J J, Wong K, et al. [J]. Treatment Options in &amp;hellip;, 2021. Springer.&amp;nbsp;[11] Schuetze S M. Gastrointestinal stromal tumor [M/OL]. 2023. Available from: https://cdn.amegroups.cn.&amp;nbsp;[12] Li B, Chen H, Yang S, et al. [J]. Molecular Cancer, 2023.&amp;nbsp;[13] Unknown authors. Clinical Cancer Research, 2020-06-29 [Online First].&amp;nbsp;[14] Wei Z W, Wu J, Huang W B, et al. [J]. The Lancet, 2020.&amp;nbsp;[15] 徐斌 . 医学综述, 2007, 13(9).</p><pub-id pub-id-type="doi"/></element-citation></ref></ref-list></back></article>
